Palvella Therapeutics, Inc. Operating Expenses
Palvella Therapeutics, Inc. (PVLA) reported Operating Expenses of $21.41 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-04
- Palvella Therapeutics, Inc. operating expenses for the quarter ending 2026-06-30 was $21.41M, a 131.41% increase year-over-year.
- Palvella Therapeutics, Inc. operating expenses for the quarter ending 2026-03-31 was $14.86M, a 88.73% increase year-over-year.
- Palvella Therapeutics, Inc. operating expenses for the quarter ending 2025-12-31 was $11.30M, a 158.91% increase year-over-year.
- Palvella Therapeutics, Inc. operating expenses for the quarter ending 2025-09-30 was $10.18M, a 101.05% increase year-over-year.
- Palvella Therapeutics, Inc. operating expenses for fiscal 2025 was $38.60M, a 173.87% increase from fiscal 2024.
- Palvella Therapeutics, Inc. operating expenses for fiscal 2024 was $14.10M, a 18.75% increase from fiscal 2023.
- Palvella Therapeutics, Inc. operating expenses for fiscal 2023 was $11.87M, a 82.89% decline from fiscal 2022.
- Palvella Therapeutics, Inc. operating expenses for fiscal 2022 was $69.38M, a 16.66% decline from fiscal 2021.
| Period end | Operating Expenses 1 month | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 7 month | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 10 month | Operating Expenses 12 month | Operating Expenses 12 month as first filed | Operating Expenses 13 month | Operating Expenses 16 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $21.41M 10-Q · filed 2026-08-04 | $36.26M 10-Q · filed 2026-08-04 | $47.56M derived: sum of 3 quarters · filed 2026-08-04 | $57.74M derived: sum of 4 quarters · filed 2026-08-04 | |||||||||
| 2026-03-31 | $14.86M 10-Q · filed 2026-05-07 | $26.16M derived: sum of 2 quarters · filed 2026-05-07 | $36.34M derived: sum of 3 quarters · filed 2026-05-07 | $45.59M derived: sum of 4 quarters · filed 2026-08-04 | |||||||||
| 2025-12-31 | $11.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $21.48M derived: sum of 2 quarters · filed 2026-03-31 | $30.73M derived: sum of 3 quarters · filed 2026-08-04 | $38.60M 10-K · filed 2026-03-31 | |||||||||
| 2025-09-30 | $10.18M 10-Q · filed 2025-11-12 | $19.43M derived: sum of 2 quarters · filed 2026-08-04 | $27.30M 10-Q · filed 2025-11-12 | $31.66M derived: sum of 4 quarters · filed 2026-08-04 | |||||||||
| 2025-06-30 | $9.25M 10-Q · filed 2026-08-04 | $17.12M 10-Q · filed 2026-08-04 | $21.49M derived: sum of 3 quarters · filed 2026-08-04 | $26.55M derived: sum of 4 quarters · filed 2026-08-04 | |||||||||
| 2025-03-31 | $7.87M 10-Q · filed 2026-05-07 | $12.24M derived: sum of 2 quarters · filed 2026-05-07 | $17.30M derived: sum of 3 quarters · filed 2026-05-07 | $20.21M derived: sum of 4 quarters · filed 2026-05-07 | |||||||||
| 2024-12-31 | $4.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $9.43M derived: sum of 2 quarters · filed 2026-03-31 | $12.34M derived: sum of 3 quarters · filed 2026-03-31 | $14.10M 10-K · filed 2026-03-31 | |||||||||
| 2024-09-30 | $5.06M 10-Q · filed 2025-11-12 | $3.13M 10-Q · filed 2024-11-13 | $7.97M derived: sum of 2 quarters · filed 2025-11-12 | $9.73M 10-Q · filed 2025-11-12 | $12.67M 10-Q · filed 2024-11-13 | -$45.17M derived: sum of 4 quarters · filed 2025-11-12 | |||||||
| 2024-06-30 | $2.91M 10-Q · filed 2025-08-14 | $4.18M 10-Q · filed 2024-08-14 | $4.67M 10-Q · filed 2025-08-14 | $9.53M 10-Q · filed 2024-08-14 | -$50.23M derived: sum of 3 quarters · filed 2025-08-14 | -$18.90M derived: sum of 4 quarters · filed 2025-08-14 | |||||||
| 2024-03-31 | $1.76M 10-Q · filed 2025-05-15 | $5.36M 10-Q · filed 2024-05-15 | -$53.14M derived: sum of 2 quarters · filed 2025-05-15 | -$21.81M derived: sum of 3 quarters · filed 2025-05-15 | -$3.82M derived: sum of 4 quarters · filed 2025-05-15 | ||||||||
| 2023-12-31 | -$54.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$23.57M derived: sum of 2 quarters · filed 2025-03-31 | -$5.58M derived: sum of 3 quarters · filed 2025-03-31 | $11.87M 10-K · filed 2025-03-31 | $72.57M 10-K · filed 2024-03-29 | ||||||||
| 2023-09-30 | $31.33M 10-Q · filed 2024-11-13 | $49.32M derived: sum of 2 quarters · filed 2024-11-13 | $66.77M 10-Q · filed 2024-11-13 | $84.13M derived: sum of 4 quarters · filed 2024-11-13 | |||||||||
| 2023-06-30 | $17.99M 10-Q · filed 2024-08-14 | $35.44M 10-Q · filed 2024-08-14 | $52.80M derived: sum of 3 quarters · filed 2024-08-14 | $70.34M derived: sum of 4 quarters · filed 2024-08-14 | |||||||||
| 2023-03-31 | $17.45M 10-Q · filed 2024-05-15 | $34.81M derived: sum of 2 quarters · filed 2024-05-15 | $52.35M derived: sum of 3 quarters · filed 2024-05-15 | $68.38M derived: sum of 4 quarters · filed 2024-05-15 | |||||||||
| 2022-12-31 | $17.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $34.90M derived: sum of 2 quarters · filed 2024-03-29 | $50.93M derived: sum of 3 quarters · filed 2024-03-29 | $69.38M 10-K · filed 2024-03-29 | |||||||||
| 2022-09-30 | $17.54M 10-Q · filed 2023-11-14 | $33.57M derived: sum of 2 quarters · filed 2023-11-14 | $52.01M 10-Q · filed 2023-11-14 | $71.45M derived: sum of 4 quarters · filed 2023-11-14 | |||||||||
| 2022-06-30 | $16.03M 10-Q · filed 2023-08-10 | $34.47M 10-Q · filed 2023-08-10 | $53.91M derived: sum of 3 quarters · filed 2023-08-10 | $76.98M derived: sum of 4 quarters · filed 2023-08-10 | |||||||||
| 2022-03-31 | $18.45M 10-Q · filed 2023-05-11 | $37.89M derived: sum of 2 quarters · filed 2023-05-11 | $60.96M derived: sum of 3 quarters · filed 2023-05-11 | $81.00M derived: sum of 4 quarters · filed 2023-05-11 | |||||||||
| 2021-12-31 | $19.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $42.51M derived: sum of 2 quarters · filed 2023-03-31 | $62.56M derived: sum of 3 quarters · filed 2023-03-31 | $83.25M 10-K · filed 2023-03-31 | |||||||||
| 2021-09-30 | $23.07M 10-Q · filed 2022-11-04 | $43.12M derived: sum of 2 quarters · filed 2022-11-04 | $63.81M 10-Q · filed 2022-11-04 | $78.09M derived: sum of 4 quarters · filed 2022-11-04 | |||||||||
| 2021-06-30 | $20.05M 10-Q · filed 2022-08-04 | $40.74M 10-Q · filed 2022-08-04 | $55.03M derived: sum of 3 quarters · filed 2022-08-04 | $70.96M derived: sum of 4 quarters · filed 2022-08-04 | |||||||||
| 2021-03-31 | $20.69M 10-Q · filed 2022-05-11 | $34.98M derived: sum of 2 quarters · filed 2022-05-11 | $50.92M derived: sum of 3 quarters · filed 2022-05-11 | $66.82M derived: sum of 4 quarters · filed 2022-05-11 | |||||||||
| 2020-12-31 | $14.29M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | $30.23M derived: sum of 2 quarters · filed 2022-03-02 | $46.13M derived: sum of 3 quarters · filed 2022-03-02 | $63.24M 10-K · filed 2022-03-02 | |||||||||
| 2020-09-30 | $15.94M 10-Q · filed 2021-11-02 | $31.84M derived: sum of 2 quarters · filed 2021-11-02 | $48.96M 10-Q · filed 2021-11-02 | $67.56M derived: sum of 4 quarters · filed 2021-11-02 | |||||||||
| 2020-06-30 | $15.90M 10-Q · filed 2021-08-05 | $33.02M 10-Q · filed 2021-08-05 | $51.62M derived: sum of 3 quarters · filed 2021-08-05 | $69.66M derived: sum of 4 quarters · filed 2021-08-05 | |||||||||
| 2020-03-31 | $17.12M 10-Q · filed 2021-05-17 | $35.72M derived: sum of 2 quarters · filed 2021-05-17 | $53.76M derived: sum of 3 quarters · filed 2021-05-17 | $71.33M derived: sum of 4 quarters · filed 2021-05-17 | |||||||||
| 2019-12-31 | $18.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $36.65M derived: sum of 2 quarters · filed 2021-03-31 | $54.21M derived: sum of 3 quarters · filed 2021-03-31 | $73.44M 10-K · filed 2021-03-31 | |||||||||
| 2019-09-30 | $18.05M 10-Q · filed 2020-11-04 | $35.61M derived: sum of 2 quarters · filed 2020-11-04 | $54.84M 10-Q · filed 2020-11-04 | $72.40M derived: sum of 4 quarters · filed 2020-11-04 | |||||||||
| 2019-06-30 | $17.56M 10-Q · filed 2020-08-10 | $36.79M 10-Q · filed 2020-08-10 | $54.35M derived: sum of 3 quarters · filed 2020-08-10 | $70.50M derived: sum of 4 quarters · filed 2020-08-10 | |||||||||
| 2019-03-31 | $19.23M 10-Q · filed 2020-05-11 | $36.79M derived: sum of 2 quarters · filed 2020-05-11 | $52.94M derived: sum of 3 quarters · filed 2020-05-11 | $66.87M derived: sum of 4 quarters · filed 2020-05-11 | |||||||||
| 2018-12-31 | $17.56M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $33.71M derived: sum of 2 quarters · filed 2020-03-13 | $47.65M derived: sum of 3 quarters · filed 2020-03-13 | $59.93M 10-K · filed 2020-03-13 | |||||||||
| 2018-09-30 | $16.15M 10-Q · filed 2019-11-12 | $30.08M derived: sum of 2 quarters · filed 2019-11-12 | $42.37M 10-Q · filed 2019-11-12 | $54.03M derived: sum of 4 quarters · filed 2019-11-12 | |||||||||
| 2018-06-30 | $13.93M 10-Q · filed 2019-08-09 | $26.22M 10-Q · filed 2019-08-09 | $37.89M derived: sum of 3 quarters · filed 2019-08-09 | $47.00M derived: sum of 4 quarters · filed 2019-08-09 | |||||||||
| 2018-03-31 | $12.29M 10-Q · filed 2019-05-10 | $23.95M derived: sum of 2 quarters · filed 2019-05-10 | $33.06M derived: sum of 3 quarters · filed 2019-05-10 | $42.81M derived: sum of 4 quarters · filed 2019-05-10 | |||||||||
| 2017-12-31 | $11.66M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $20.77M derived: sum of 2 quarters · filed 2019-03-18 | $30.52M derived: sum of 3 quarters · filed 2019-03-18 | $39.87M 10-K · filed 2019-03-18 | |||||||||
| 2017-09-30 | $9.11M 10-Q · filed 2018-11-07 | $9.11M 10-Q · filed 2017-11-13 | $18.86M derived: sum of 2 quarters · filed 2018-11-07 | $28.20M 10-Q · filed 2018-11-07 | $28.20M 10-Q · filed 2017-11-13 | $37.34M derived: sum of 4 quarters · filed 2018-11-07 | |||||||
| 2017-06-30 | $9.74M 10-Q · filed 2018-08-09 | $9.74M 10-Q · filed 2017-08-11 | $19.09M 10-Q · filed 2018-08-09 | $19.09M 10-Q · filed 2017-08-11 | $28.22M derived: sum of 3 quarters · filed 2018-08-09 | $35.19M derived: sum of 4 quarters · filed 2018-08-09 | |||||||
| 2017-03-31 | $9.35M 10-Q · filed 2018-05-10 | $9.35M 10-Q · filed 2017-05-15 | $18.48M derived: sum of 2 quarters · filed 2018-05-10 | $25.44M derived: sum of 3 quarters · filed 2018-05-10 | $32.31M derived: sum of 4 quarters · filed 2018-05-10 | ||||||||
| 2016-12-31 | $9.13M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $16.09M derived: sum of 2 quarters · filed 2018-03-15 | $22.96M derived: sum of 3 quarters · filed 2018-03-15 | $28.59M 10-K · filed 2018-03-15 | $28.59M 10-K · filed 2017-03-30 | ||||||||
| 2016-09-30 | $6.96M 10-Q · filed 2017-11-13 | $13.83M derived: sum of 2 quarters · filed 2017-11-13 | $19.46M 10-Q · filed 2017-11-13 | $24.16M derived: sum of 4 quarters · filed 2017-11-13 | |||||||||
| 2016-06-30 | $6.87M 10-Q · filed 2017-08-11 | $12.50M 10-Q · filed 2017-08-11 | $17.20M derived: sum of 3 quarters · filed 2017-08-11 | $21.49M derived: sum of 4 quarters · filed 2017-08-11 | |||||||||
| 2016-03-31 | $5.63M 10-Q · filed 2017-05-15 | $10.33M derived: sum of 2 quarters · filed 2017-05-15 | $14.63M derived: sum of 3 quarters · filed 2017-05-15 | $18.32M derived: sum of 4 quarters · filed 2017-05-15 | |||||||||
| 2015-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $9.00M derived: sum of 2 quarters · filed 2017-03-30 | $12.69M derived: sum of 3 quarters · filed 2017-03-30 | $16.61M 10-K · filed 2017-03-30 | |||||||||
| 2015-09-30 | $4.29M 10-Q · filed 2016-11-10 | $7.99M derived: sum of 2 quarters · filed 2016-11-10 | $11.91M 10-Q · filed 2016-11-10 | $17.10M derived: sum of 4 quarters · filed 2016-11-10 | |||||||||
| 2015-06-30 | $3.69M 10-Q · filed 2016-08-11 | $7.61M 10-Q · filed 2016-08-11 | $12.80M derived: sum of 3 quarters · filed 2016-08-11 | $14.66M derived: sum of 4 quarters · filed 2016-08-11 | |||||||||
| 2015-03-31 | $3.92M 10-Q · filed 2016-05-12 | $9.11M derived: sum of 2 quarters · filed 2016-05-12 | $10.97M derived: sum of 3 quarters · filed 2016-05-12 | $10.98M derived: sum of 4 quarters · filed 2016-05-12 | |||||||||
| 2014-12-31 | $5.19M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | $7.05M derived: sum of 2 quarters · filed 2016-03-23 | $7.06M derived: sum of 3 quarters · filed 2016-03-23 | $12.56M 10-K · filed 2016-03-23 | |||||||||
| 2014-09-30 | $1.86M 10-Q · filed 2015-11-13 | $13.92K 10-Q · filed 2014-11-13 | $1.87M derived: sum of 2 quarters · filed 2015-11-13 | $7.37M 10-Q · filed 2015-11-13 | $1.87M derived: sum of 4 quarters · filed 2015-11-13 | $29.90K 10-Q · filed 2014-12-12 | |||||||
| 2014-06-30 | $6.21K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-12 | $7.75K derived: sum of 2 quarters · filed 2014-09-12 | $9.95K derived: sum of 3 quarters · filed 2014-09-12 | $15.71K 10-K · filed 2014-09-12 | $15.99K 10-K · filed 2014-09-12 | ||||||||
| 2014-03-31 | $1.54K 10-Q · filed 2014-06-02 | $3.74K derived: sum of 2 quarters · filed 2014-06-02 | $9.50K 10-Q · filed 2014-06-02 | $9.50K 10-Q · filed 2014-06-02 | |||||||||
| 2013-12-31 | $2.20K 10-Q · filed 2014-05-14 | $7.96K 10-Q · filed 2014-05-14 | $7.96K 10-Q · filed 2014-05-14 | ||||||||||
| 2013-09-30 | $5.76K 10-Q · filed 2014-12-12 | ||||||||||||
| 2013-06-30 | $274.00 10-K · filed 2014-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |